Synovus Financial Corp Biomarin Pharmaceutical Inc Transaction History

Synovus Financial Corp

  • $8.56 Billion
  • Q3 2024

A detailed history of Synovus Financial Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Synovus Financial Corp holds 30,253 shares of BMRN stock, worth $2.02 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
30,253
Previous 30,253 -0.0%
Holding current value
$2.02 Million
Previous $2.13 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$69.02 - $93.84 $427,302 - $580,963
6,191 Added 25.73%
30,253 $2.13 Million
Q2 2024

Aug 13, 2024
BUY
$74.43 - $92.22 $44,434 - $55,055
597 Added 2.54%
24,062 $1.98 Million
Q1 2024

May 14, 2024
BUY
$83.81 - $99.0 $26,735 - $31,581
319 Added 1.38%
23,465 $2.05 Million
Q3 2023

Nov 13, 2023
BUY
$85.07 - $94.48 $423,053 - $469,849
4,973 Added 27.36%
23,146 $2.05 Million
Q2 2023

Aug 08, 2023
SELL
$86.68 - $100.3 $67,957 - $78,635
-784 Reduced 4.14%
18,173 $1.58 Million
Q1 2023

May 11, 2023
SELL
$87.74 - $117.27 $138,629 - $185,286
-1,580 Reduced 7.69%
18,957 $1.84 Million
Q4 2022

Feb 06, 2023
BUY
$80.93 - $108.63 $46,130 - $61,919
570 Added 2.85%
20,537 $2.13 Million
Q3 2022

Oct 27, 2022
SELL
$82.16 - $96.94 $8,216 - $9,694
-100 Reduced 0.5%
19,967 $1.69 Million
Q2 2022

Aug 10, 2022
BUY
$71.48 - $86.85 $34,667 - $42,122
485 Added 2.48%
20,067 $1.66 Million
Q1 2022

May 12, 2022
SELL
$74.28 - $92.69 $100,946 - $125,965
-1,359 Reduced 6.49%
19,582 $1.51 Million
Q4 2021

Feb 14, 2022
BUY
$71.72 - $91.47 $78,461 - $100,068
1,094 Added 5.51%
20,941 $1.85 Million
Q3 2021

Nov 08, 2021
BUY
$74.77 - $85.47 $102,883 - $117,606
1,376 Added 7.45%
19,847 $1.53 Million
Q2 2021

Aug 11, 2021
BUY
$75.51 - $84.79 $40,322 - $45,277
534 Added 2.98%
18,471 $1.55 Million
Q1 2021

May 11, 2021
SELL
$74.73 - $90.69 $2.34 Million - $2.84 Million
-31,308 Reduced 63.58%
17,937 $1.35 Million
Q4 2020

Feb 11, 2021
BUY
$72.61 - $90.2 $31,367 - $38,966
432 Added 0.89%
49,245 $4.32 Million
Q3 2020

Nov 09, 2020
BUY
$71.87 - $131.03 $901,465 - $1.64 Million
12,543 Added 34.58%
48,813 $3.71 Million
Q2 2020

Aug 10, 2020
SELL
$79.55 - $124.22 $664,719 - $1.04 Million
-8,356 Reduced 18.72%
36,270 $4.47 Million
Q1 2020

Apr 24, 2020
BUY
$71.37 - $96.85 $455,697 - $618,387
6,385 Added 16.7%
44,626 $3.78 Million
Q4 2019

Feb 06, 2020
BUY
$64.27 - $86.37 $132,781 - $178,440
2,066 Added 5.71%
38,241 $3.23 Million
Q3 2019

Nov 01, 2019
BUY
$67.4 - $85.11 $68,950 - $87,067
1,023 Added 2.91%
36,175 $2.44 Million
Q2 2019

Aug 08, 2019
BUY
$80.35 - $93.9 $264,431 - $309,024
3,291 Added 10.33%
35,152 $3.01 Million
Q1 2019

May 09, 2019
SELL
$84.2 - $98.62 $3,031 - $3,550
-36 Reduced 0.11%
31,861 $2.82 Million
Q4 2018

Feb 07, 2019
SELL
$80.14 - $106.07 $13,463 - $17,819
-168 Reduced 0.52%
31,897 $2.72 Million
Q3 2018

Nov 01, 2018
BUY
$93.92 - $105.72 $64,523 - $72,629
687 Added 2.19%
32,065 $3.11 Million
Q2 2018

Aug 01, 2018
SELL
$76.01 - $99.03 $66,356 - $86,453
-873 Reduced 2.71%
31,378 $2.95 Million
Q1 2018

May 07, 2018
BUY
$77.67 - $92.63 $296,544 - $353,661
3,818 Added 13.43%
32,251 $2.62 Million
Q4 2017

Feb 09, 2018
BUY
$80.76 - $95.13 $397,177 - $467,849
4,918 Added 20.91%
28,433 $2.54 Million
Q3 2017

Nov 13, 2017
BUY
$80.6 - $94.95 $1.9 Million - $2.23 Million
23,515
23,515 $2.18 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email